Personal information

No personal information available

Activities

Education and qualifications (5)

Institut Pasteur: Paris, Île-de-France, FR

2018-10-15 to present | PhD (Department of Virology)
Education
Source: Self-asserted source
Luca Murer

Institute of Molecular Life Sciences: Zurich, Zurich, CH

2016-06-01 to present | PhD (Department of Molecular Life Sciences)
Education
Source: Self-asserted source
Luca Murer

Institute of Medical Virology: Zurich, Zurich, CH

2015-01-01 to 2016-03-02 | MSc. (Institute of Medical Virology)
Education
Source: Self-asserted source
Luca Murer

Universitätsklinikum Freiburg Institut für Medizinische Mikrobiologie und Hygiene: Freiburg, Baden-Württemberg, DE

2015-08-01 to 2015-12-31 | MSc (Department für Medizinische Mikrobiologie und Hygiene)
Education
Source: Self-asserted source
Luca Murer

University of Zurich: Zurich, Zurich, CH

2011-08-13 to 2014-12-21 | BSc.
Education
Source: Self-asserted source
Luca Murer

Works (9)

Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern

Current Research in Virological Science
2022 | Journal article
Contributors: Luca Murer; Romain Volle; Vardan Andriasyan; Anthony Petkidis; Alfonso Gomez-Gonzalez; Liliane Yang; Nicole Meili; Maarit Suomalainen; Michael Bauer; Daniela Policarpo Sequeira et al.
Source: check_circle
Crossref

Methylene blue, Mycophenolic acid, Posaconazole, and Niclosamide inhibit SARS-CoV-2Omicron variant BA.1 infection of human airway epithelial explant cultures

2022-03-31 | Preprint
Contributors: Romain Volle; Luca Murer; Anthony Petkidis; Vardan Andriasyan; Alessandro Savi; Cornelia Bircher; Nicole Meili; Lucy Fischer; Daniela Policarpo Sequeira; Daniela Katharina Mark et al.
Source: check_circle
Crossref

Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating

Journal of Virology
2022-01-26 | Journal article
Contributors: Luca Murer; Anthony Petkidis; Thomas Vallet; Marco Vignuzzi; Urs F. Greber; Bryan R. G. Williams
Source: check_circle
Crossref

Arrayed multicycle drug screens identify broadly acting chemical inhibitors for repurposing against SARS-CoV-2

2021-03-31 | Preprint
Contributors: Luca Murer; Romain Volle; Vardan Andriasyan; Nicole Meili; Liliane Yang; Daniela Sequeira; Afonso Gomez-Gonzalez; Anthony Petkidis; Dominik Olszewski; Michael Bauer et al.
Source: check_circle
Crossref

The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus

Antimicrobial Agents and Chemotherapy
2020-08-20 | Journal article
Contributors: Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich et al.
Source: check_circle
Crossref

A high-content image-based drug screen of clinical compounds against cell transmission of adenovirus

Scientific Data
2020-08-12 | Journal article
Part of ISSN: 2052-4463
Source: Self-asserted source
Luca Murer

The FDA-approved drug Nelfinavir inhibits lytic cell-free transmission of human adenoviruses

2020-05-15 | Preprint
Contributors: Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich et al.
Source: check_circle
Crossref

High-content image-based drug screen identifies a clinical compound against cell transmission of adenovirus

2020-03-25 | Preprint
Contributors: Fanny Georgi; Fabien Kuttler; Luca Murer; Vardan Andriasyan; Robert Witte; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Source: check_circle
Crossref

A Single Point Mutation in the Rhinovirus 2B Protein Reduces the Requirement for Phosphatidylinositol 4-Kinase Class III Beta in Viral Replication

Journal of virology
2018 | Journal article
Source: Self-asserted source
Luca Murer